Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Ovarian Neoplasms

Free Subscription 01.12.2025 1 Anticancer Drugs 1 BMC Cancer 1 Cancer Lett 3 Gynecol Oncol 1 Int J Gynaecol Obstet 1 Oncogene 1 Oncol Rep

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Anticancer Drugs

1. JIANG Y, Yi Q, Wang Y, Li C, et al
   Treatment of HRD-positive elderly ovarian cancer patient: a case report.
   Anticancer Drugs. 2025 Nov 5. doi: 10.1097/CAD.0000000000001772.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. FADAVI Z, Alizadeh H, Mowla SJ, Soltani BM, et al
   MEF2C induces intrinsic apoptosis and reverses cisplatin resistance in A2780 ovarian cancer cell line.
   BMC Cancer. 2025 Nov 24. doi: 10.1186/s12885-025-15348.
   PubMed         Abstract available
   
   

   
   Cancer Lett

3. LIAO B, Chen L, Ruan J, Wang R, et al
   Microbiome and gartynecologic cancer.
   Cancer Lett. 2026;636:217940.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

4. SOPPE SE, Kuo TM, Lyratzopoulos G, DeRouen MC, et al
   Symptom-related care and diagnoses before ovarian cancer detection: Patterns and differences by cancer stage.
   Gynecol Oncol. 2025;204:100-108.
   PubMed         Abstract available
   
   
5. EVERT JSH, de Jonge PKJD, Zusterzeel PLM, Hobo W, et al
   Intraperitoneal infusion of stem cell-derived natural killer cells in recurrent epithelial ovarian cancer patients: Results of the phase 1 INTRO-01 trial.
   Gynecol Oncol. 2025;204:91-99.
   PubMed         Abstract available
   
   
6. HAYAKAWA M, Nakajima H, Harano K, Watanabe S, et al
   Impact of platinum-free interval and bevacizumab on second-line chemotherapy following progression on first-line PARP inhibitor maintenance in advanced ovarian cancer: A retrospective cohort study.
   Gynecol Oncol. 2025;204:70-78.
   PubMed         Abstract available
   
   

   
   Int J Gynaecol Obstet

7. ARENA A, Franceschini C, Mantovani E, Virgilio A, et al
   Conservative hysteroscopic treatment of endometrial intraepithelial neoplasia and endometrial cancer in patients with high surgical risk with mechanical hysteroscopic tissue removal systems: A retrospective cohort study.
   Int J Gynaecol Obstet. 2025 Jun 18. doi: 10.1002/ijgo.70320.
   PubMed         Abstract available
   
   

   
   Oncogene

8. LIU S, He Y, Ning X, Xu W, et al
   SLC7A5-ERBB2 axis drives olaparib resistance via de novo lipid synthesis in ovarian cancer.
   Oncogene. 2025 Nov 28. doi: 10.1038/s41388-025-03584.
   PubMed         Abstract available
   
   

   
   Oncol Rep

9. ZHAO J, Ye W, Wu J, Liu L, et al
   [Retracted] Sp1?CD147 positive feedback loop promotes the invasion ability of ovarian cancer.
   Oncol Rep. 2026;55:25.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.